Biocept, Inc. Profile Avatar - Palmy Investing

Biocept, Inc.

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthc…

Medical - Diagnostics & Research
US, San Diego [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of BIOC's Analysis
CIK: 1044378 CUSIP: 09072V402 ISIN: US09072V6002 LEI: - UEI: -
Secondary Listings
BIOC has no secondary listings inside our databases.